Rachel Lenington
Chief Operating Officer bei ATHIRA PHARMA, INC.
Vermögen: 36 702 $ am 31.03.2024
Profil
Rachel Lenington is currently the Chief Operating & Development Officer at Athira Pharma, Inc. She previously worked as the Director & Manager-Global Program at Amgen, Inc. from 2000 to 2010 and as the Deputy Director-Strategy, Planning & Management at the Bill & Melinda Gates Foundation from 2010 to 2015.
Ms. Lenington also held the position of Senior VP-Program & Portfolio Management at Seagen Inc. Ms. Lenington completed her undergraduate degree at the University of Washington in 1995 and earned an MBA from Pepperdine University in 2005.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ATHIRA PHARMA, INC.
0,03% | 14.02.2024 | 13 395 ( 0,03% ) | 36 702 $ | 31.03.2024 |
Aktive Positionen von Rachel Lenington
| Unternehmen | Position | Beginn |
|---|---|---|
| ATHIRA PHARMA, INC. | Chief Operating Officer | 18.10.2021 |
Ehemalige bekannte Positionen von Rachel Lenington
| Unternehmen | Position | Ende |
|---|---|---|
Bill & Melinda Gates Foundation
 Bill & Melinda Gates Foundation Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Foundation is a nonprofit organization that aims to help people lead healthy and productive lives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. The company's mission is to create a world where everyone has equal opportunities. The company is guided by the belief that every life has equal value. The foundation is currently working on 'the big catch-up' project, which aims to increase vaccination levels among children to pre-pandemic levels and strengthen primary healthcare services for essential immunization in the future. The company was founded by Melinda French Gates and William H. Gates, and the CEO is Mark Suzman. | Corporate Officer/Principal | 01.01.2015 |
| AMGEN INC. | Director/Board Member | 01.01.2010 |
| SEAGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Rachel Lenington
| University of Washington | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Foundation is a nonprofit organization that aims to help people lead healthy and productive lives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. The company's mission is to create a world where everyone has equal opportunities. The company is guided by the belief that every life has equal value. The foundation is currently working on 'the big catch-up' project, which aims to increase vaccination levels among children to pre-pandemic levels and strengthen primary healthcare services for essential immunization in the future. The company was founded by Melinda French Gates and William H. Gates, and the CEO is Mark Suzman. | Commercial Services |
